Dose-response analyses of experimental cancer data

Drug Metabolism Reviews

Volumn 32, Issue 2, 2000, Pages 193-209

  Melnick, Ronald L ^a   Kohn, Michael C ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,3 BUTADIENE; CHLOROPRENE; ISOPRENE;

CANCER RESEARCH; CANCER RISK; CANCER SURVIVAL; CARCINOGENESIS; CARCINOGENICITY; CONFERENCE PAPER; DOSIMETRY; EXPERIMENTAL NEOPLASM; FEMALE; KIDNEY CANCER; MOUSE; NONHUMAN;

ANIMALS; CARCINOGENICITY TESTS; CARCINOGENS; DATA INTERPRETATION, STATISTICAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MICE; NEOPLASMS, EXPERIMENTAL; RATS; RISK ASSESSMENT; RISK FACTORS;

EID: 0034038041     PISSN: 03602532     EISSN: None     Source Type: Journal    
DOI: 10.1081/DMR-100100572     Document Type: Conference Paper

References (24)

1. R. L. Melnick, J. Huff, B. J. Chou, and R. Miller, Carcinogenicity of 1,3-butadiene in C57BL/6 × C3H F1 mice at low exposure concentrations, Cancer Res., 50, 6592-6599 (1990).
2. C. J. Portier and A. J. Bailer, Testing for increased carcinogenicity using a survival-adjusted quantal response test, Fundam. Appl. Toxicol., 12, 731-737 (1989).
3. C. J. Portier, J. C. Hedges, and J. D. Hoel, Age-specific models of mortality and tumor onset for historical control animals in the National Toxicology Program's carcinogenicity experiments, Cancer Res., 46, 4372-4378 (1986).
4. 1 mice and comparison of dose-response with 1,3-butadiene in mice. Carcinogenesis, 20, 867-878 (1999).
5. M. C. Kohn and R. L. Melnick, Species differences in the production and clearance of butadiene metabolites: A mechanistic model indicates predominantly physiological, not biochemical, control. Carcinogenesis, 14, 619-628 (1993).
6. National Toxicology Program, Toxicology and carcinogenesis studies of isoprene (CAS No. 78-79-5) in F344/N rats (inhalation studies), Technical Report NTP-TR-486. NIH Publication No. 97-3976, National Institutes of Health, Research Triangle Park, NC, 1999, pp. 1-176.
7. 1 mice exposed to trihalomethanes, Toxicol. Appl. Pharmacol., 148, 137-147 (1998).
8. J. E. Huff, R. L. Melnick, H. A. Solleveld, J. K. Haseman, M. Powers, and R. A. Miller, Multiple organ carcinogenicity of 1,3-butadiene in B6C3F1 mice after 60 weeks of inhalation exposure, Science, 227, 548-549 (1985).
9. J. M. Fajen, D. R. Roberts, L. J. Ungers, and E. R. Krishnan, Occupational exposure of workers to 1,3-butadiene, Environ. Health Perspect., 861, 11-18 (1990).
10. A. J. Bailer and C. J. Portier, Effects of treatment-induced mortality and tumor-induced mortality on tests for carcinogenicity in small samples, Biometrics, 44, 417-431 (1988).
11. M. C. Kohn and R. L. Melnick, Effects of the structure of a toxicokinetic model of butadiene inhalation exposure on computed production of carcinogenic intermediates. Toxicology, 113, 31-39 (1996).
12. E. Malvoisin and M. Roberfroid, Hepatic microsomal metabolism of 1,3-butadiene. Xenobiotica, 12, 137-144 (1982).
13. G. A. Csanády, F. P. Guengerich, and J. A. Bond, Comparison of the biotransformation of 1,3-butadiene and its metabolite, butadiene monoepoxide, by hepatic and pulmonary tissues from humans, rats, and mice, Carcinogenesis, 13, 1143-1153 (1992).
14. C. de Meester, F. Poncelet, M. Roberfroid, and M. Mercier, The mutagenicity of butadiene towards Salmonella typhimurium, Toxicol. Lett., 6, 125-130 (1980).
15. C. de Meester, F. Poncelet, M. Roberfroid, and M. Mercier, Mutagenicity of butadiene and butadiene monoxide, Biochem. Biophys. Res. Commun., 80, 298-305 (1978).
16. M. J. Wade, J. W. Moyer, and C. H. Hine, Mutagenic action of a series of epoxides, Mutat. Res., 66, 367-371 (1979).
17. International Agency for Research on Cancer, 1,3-Butadiene, in Evaluation of Carcinogenic Risks to Humans, Occupational Exposures to Mists and Vapours from Strong Inorganic Acids; and other Industrial Chemicals, IARC Monograph Vol. 54, IARC, Lyon, 1992, pp. 237-285.
18. R. L. Melnick, R. C. Sills, J. H. Roycroft, B. J. Chou, H. A. Ragan, and R. A. Miller, Isoprene, an endogenous hydrocarbon and industrial chemical, induces multiple organ neoplasia in rodents after 26 weeks of inhalation exposure. Cancer Res., 54, 5333-5339 (1994).
19. P. G. Gervasi and V. Longo, Metabolism and mutagenicity of isoprene, Environ. Health Perspect., 86, 85-87 (1990).
20. J. K. Dunnick and R. L. Melnick, Assessment of the carcinogenic potential of chlorinated water: Experimental studies of chlorine, chloramine, and trihalomethanes. J. Natl. Cancer Inst., 85, 817-822 (1993).
21. 1 mice: Comparison of administration by gavage in corn oil vs ad libitum in drinking water, Fundam. Appl. Toxicol., 22, 90-102 (1994).
22. J. L., Larson, D. C. Wolf, and B. E. Butterworth, Induced regenerative cell proliferation in livers and kidney of male F-344 rats given chloroform in corn oil by gavage or ad libitum in drinking water, Toxicology, 95, 73-86 (1995).
23. J. L. Larson, D. C. Wolf, S. Méry, K. T. Morgan, and B. E. Butterworth, Toxicity and cell proliferation in the liver, and kidneys and nasal passages of female F-344 rats induced by chloroform administered by gavage, Food. Chem. Toxicol., 33, 443-456 (1995).
24. 1 mice, Fundam. Appl. Toxicol., 5, 760-769 (1985).